Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Cancer therapy continues to evolve, with increasing focus on targeted treatments and leveraging the body's own immune system. Among the innovative compounds gaining traction is Oglufanide, also known as H-Glu-Trp-OH (CAS 38101-59-6) or Thymogen. This dipeptide has shown significant promise in the realm of peptide-based cancer therapy development due to its unique dual mechanism of action: angiogenesis inhibition and immunomodulation.
A critical aspect of Oglufanide's anti-cancer potential lies in its ability to inhibit vascular endothelial growth factor (VEGF). VEGF is a potent signaling protein that promotes the growth of new blood vessels, a process known as angiogenesis, which is vital for tumor growth and metastasis. By disrupting this process, Oglufanide acts as a potent H-Glu-Trp-OH cancer angiogenesis inhibitor, effectively starving tumors of their blood supply and limiting their expansion. This makes it a compelling candidate for new oncology drug formulations.
Beyond its direct anti-angiogenic effects, Oglufanide is also a known immunomodulator. It stimulates the immune response, helping the body to recognize and combat cancerous cells more effectively. This synergistic action of inhibiting tumor blood supply while simultaneously boosting the immune system offers a powerful one-two punch against various malignancies, including solid tumor cancers and Kaposi's sarcoma, as highlighted in numerous research studies.
Pharmaceutical companies and research institutions seeking to integrate Oglufanide into their drug discovery pipelines are advised to partner with reliable Oglufanide suppliers. NINGBO INNO PHARMCHEM CO.,LTD. provides high-purity Oglufanide, ensuring the quality and consistency necessary for rigorous cancer research and development. The availability of high-quality raw materials is crucial for developing safe and effective new therapies.
The ongoing research into Oglufanide's mechanisms and clinical applications underscores its importance in the future of cancer treatment. Its potential to not only directly impact tumor growth but also to fortify the patient's immune defenses positions it as a key component in the next generation of oncology drugs, offering renewed hope for patients battling various forms of cancer.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
